Mr. Paulson has served as a member of our board of directors since February 2020. He brings over 25 years of global biopharmaceutical industry experience, including various international leadership roles transforming organizations and developing highly successful teams across three continents. He has launched best-in-class products across multiple therapeutic areas including oncology medicines. Mr. Paulson is currently Executive Vice President and Chief Executive Officer of Ipsen North America, a global biopharmaceutical company focused on innovation and specialty care, where he is responsible for driving continued growth in both the U.S. and Canadian markets across key therapeutics areas of oncology, neurology, and rare diseases. He serves as a member of the BIO Health Section Governing Board (HSGB) and an interim director on the PhRMA Board of Directors. Prior to joining Ipsen, Mr. Paulson had a 10-year career at Amgen. While at Amgen, he held numerous regional positions including General Manager, Central and Eastern Europe, and General Manager Germany, before leading Amgen’s U.S. Oncology Business Unit. Prior to joining Amgen, he held international positions in general management, marketing and market access at Pfizer. He also served in a number of sales and marketing roles with increasing seniority for GlaxoWellcome in Canada. Mr. Paulson earned his undergraduate degree in Commerce from the University of Saskatchewan, Canada, and his MBA from the University of Toronto, Canada.